Press "Enter" to skip to content

New patent expiration for Glaxosmithkline Llc drug REQUIP XL

0
Copyright © DrugPatentWatch. Originally published at New patent expiration for Glaxosmithkline Llc drug REQUIP XL

Annual Drug Patent Expirations for REQUIP+XL
Annual Drug Patent Expirations for REQUIP+XL

Requip Xl is a drug marketed by Glaxosmithkline Llc and is included in one NDA. There are two patents protecting this drug and seven Paragraph IV challenges.

REQUIP XL drug price trends.

This drug has forty-eight patent family members in twenty-seven countries.

The generic ingredient in REQUIP XL is ropinirole hydrochloride. Additional details are available on the ropinirole hydrochloride profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Glaxosmithkline Llc drug REQUIP XL
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions